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NEW PREPARATIONS
SONERYL
THE demand for a Soneryl suppository of greater strength than the existing 3-grain
product has led to the introduction of a new packing:-5 x 10-grain suppositories.
Soneryl has proved of outstanding value in conditions necessitating the
administration of a hypnotic and sedative. In rapidity of action and of elimination
it approaches the ideal qualifications required in a preparation of this nature. The
packing of 5 x 3-grain suppositories is supplemented by the addition of the new
pack referred to above.
Pharmaceutical Specialities (Mlay & Baker) Limited, Dagenham, will be glad
to send full details of Soneryl, on request, to any member of the medical profession.
PROSEPTASINE AND SOLUSEPTASINE FOR USE IN
H)EMOLYTIC STREPTOCOCCAL INFECTIONS
THE low toxicity of Proseptasine, due to the introduction of the benzyl group
p-amino-benzenesulphonamide, has been amply demonstrated both in the laboratory
and in clinical practice. This extra margin of safety has enabled Proseptasine to
maintain its position as one of the best tolerated products for the treatment of
haemolytic streptococcal and other acute microbic infections.
Soluseptasine, for parenteral administration, is the only colourless sulphonamide
available in concentrated aqueous solution. It is widely used in conjunction with
Proseptasine for the treatment of erysipelas, puerperal sepsis, and septic.emia.
A new leaflet on Proseptasine and Soluseptasine has recently appeared, and a copy
has bean sent to us by the makers, Pharmaceutical Specialities (May & Baker) Ltd.,
of Dagenham, Essex.
Copies of the leaflet on Proseptasine and Soluseptasine may be obtained by
members of the medical profession on request to the makers at the above address.
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